8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2022 / Literature review
A review of multiple databases identified 104 relevant studies assessing the health effects of voluntary cold-water immersion (CWI) in humans. Studies indicated that CWI seems to reduce and/or transform body adipose tissue, reduce insulin resistance, and improve insulin sensitivity, which may offer protective effects against cardiovascular, obesity, and metabolic diseases. However, clear conclusions were limited by small sample sizes, often single-gender groups, and variations in water temperature and salt composition.
Esperland D, de Weerd L, Mercer JB Int J Circumpolar Health, 2022. PMID 36137565
2022 / Evidence-based dietary guideline
An Expert Panel developed a food-based intake recommendation for flavan-3-ols based on a review of 157 randomized controlled trials and 15 cohort studies using the Academy of Nutrition and Dietetics Evidence to Decision Framework. Moderate evidence supported cardiometabolic protection from dietary flavan-3-ol intake in the range of 400-600 mg/d. Increasing dietary intake was found to improve blood pressure, cholesterol levels, and blood sugar, with the strongest evidence for systolic blood pressure, total cholesterol, HDL cholesterol, and insulin/glucose dynamics. This recommendation is food-based and not intended for supplements.
Crowe-White KM, Evans LW, Kuhnle GGC, et al. Adv Nutr, 2022. PMID 36190328
2021 / Systematic review
Authors searched PubMed for studies assessing the impact of omega-3 fatty acids on coronary heart disease and mortality. The review noted that most studies, largely observational, suggested a potential benefit on coronary heart disease, although others yielded conflicting results. The authors concluded that more adequately sized randomized controlled trials are needed to clarify the risks and benefits for cardiovascular disease.
Shows an association, not proof of cause and effect.
Asfaw A, Minhas S, Khouzam AR, et al. Curr Probl Cardiol, 2021. PMID 33097299
2021 / Narrative review
This review evaluates the long-term efficacy and safety of medical treatments for obesity alongside lifestyle interventions. Recent meta-analyses indicate that 12-month placebo-subtracted weight reduction ranges from 2.9% to 6.8% across various agents: phentermine/topiramate (6.8%), liraglutide (5.4%), naltrexone/bupropion (4.0%), orlistat (2.9%), and lorcaserin (3.1%). Lorcaserin was withdrawn by the FDA in February 2020 due to an increased risk of cancer observed in a clinical trial. Currently approved drugs for chronic management (orlistat, phentermine/topiramate, naltrexone/bupropion, and liraglutide) can be costly and have adverse effects, requiring individualized benefit-risk assessment.
Tak YJ, Lee SY Curr Obes Rep, 2021. PMID 33410104
2021 / Narrative review
This narrative review evaluated recent studies published between 2014 and 2020 on interactions between genetic variations and dietary interventions on blood cholesterol concentrations. Significant SNP-diet interactions that replicated earlier associations were identified across 14 cholesterol-related genes: NPC1L1, ABCA1, ABCG5, ABCG8, APOA1, APOA2, APOA5, APOB, APOE, CETP, CYP7A1, DHCR7, LPL, and LIPC. Combinations of SNPs were also shown in some studies to explain a higher proportion of variability. The authors note that some findings still require replication in larger and more diverse study populations.
Abdullah MMH, Vazquez-Vidal I, Baer DJ, et al. Nutrients, 2021. PMID 33671529
2021 / Narrative review
This overview reviews the impact of polyphenols and polyphenolic foods on longevity and age-related conditions. Studies suggest dietary polyphenols can improve insulin resistance, diabetes risk factors, inflammation, and oxidative stress, and polyphenol intake is associated with reduced aging in humans. In vitro and in vivo evidence shows polyphenols ameliorate age-related phenotypes such as impaired proteostasis and cellular senescence, and the anti-aging action of polyphenol-rich diets like those in Blue zones is discussed.
Shows an association, not proof of cause and effect.
Meccariello R, D'Angelo S Antioxidants (Basel), 2021. PMID 33805092
2021 / Historical and policy review
This article reviews the history of research, advocacy, and regulatory actions that resulted in removing artificial trans fat from the US food supply. Synthesizing published studies, legislative histories, FDA regulatory dockets, and advocate records, the authors describe the process leading to the FDA declaring partially hydrogenated oils no longer Generally Recognized as Safe. The removal of trans fat from food in the United States is noted to prevent an estimated 50,000 premature deaths a year.
Amico A, Wootan MG, Jacobson MF, et al. Milbank Q, 2021. PMID 34342900
2021 / Narrative review
This review examines the role of the sulfur-containing amino acid taurine in mitochondrial health beyond its antioxidant properties. Taurine is found abundantly in tissues such as the heart, brain, retina, and skeletal muscles, and was approved in Japan in 1985 as a treatment for heart failure patients. Accumulated research indicates that taurine supplementation protects against pathologies linked to mitochondrial defects, including aging, cardiovascular diseases, cancer, metabolic syndrome, and neurological disorders. The authors overview mitochondrial biology, discuss taurine's maintenance of mitochondrial function, and review reported studies on its current use in several mitochondria-associated pathologies in humans.
Jong CJ, Sandal P, Schaffer SW Molecules, 2021. PMID 34443494
2021 / Expert panel narrative review
A multidisciplinary expert panel convened by the Nutrition Foundation of Italy critically evaluated and summarized literature on phytosterols for plasma cholesterol control. The panel noted that phytosterols are frequently self-prescribed without health professional advice, leading to inappropriate use or use where no significant benefit is obtained. The panel concluded that using phytosterols as supplements or functional foods to control LDL cholesterol should be preceded by assessing cardiovascular risk, lipid profile, correct understanding of product use, and willingness to pay.
Poli A, Marangoni F, Corsini A, et al. Nutrients, 2021. PMID 34444970
2021 / Narrative synthesis and review
This narrative synthesis evaluated scientific literature on ultra-processed foods (UPFs), processing technologies, and health outcomes. Observational surveys have linked greater consumption of UPFs to obesity, unfavorable cardiometabolic risk factor profiles, and increased risk for non-communicable diseases. However, whether specific food processing techniques leading to ultra-processed formulations are responsible for these observed links remains elusive and far from being understood.
Shows an association, not proof of cause and effect.
Capozzi F, Magkos F, Fava F, et al. Nutrients, 2021. PMID 34836203
2021 / Narrative review
This review summarizes scientific data on the preventive and therapeutic roles of plant-based diets (vegan and lacto-ovo-vegetarian) in cardiovascular disease, cancer, diabetes, obesity, and osteoporosis. The authors report that plant-based diets are safe and effective for all life cycle stages, including pregnancy, lactation, childhood, and old age, and are associated with a diverse gut microbiota. Nutritional concerns regarding intake of vitamin B12, calcium, vitamin D, iron, zinc, and omega-3 fats are discussed alongside guidance on fortified foods and supplementation.
Craig WJ, Mangels AR, Fresán U, et al. Nutrients, 2021. PMID 34836399
2021 / Review of prospective cohort studies
This review evaluated the impact of adjusting for diet quality or dietary patterns on reported associations between ultra-processed food (UPF) intake and health outcomes in prospective cohort studies. The authors found that the majority of associations between UPFs, obesity, and health-related outcomes remained significant and unchanged in magnitude after adjusting for diet quality or pattern. These findings suggest that the adverse consequences of UPFs are independent of dietary quality or pattern.
Shows an association, not proof of cause and effect.
Dicken SJ, Batterham RL Nutrients, 2021. PMID 35010898
2020 / Narrative review
Poor dietary quality is a primary contributor to US mortality and cardiovascular risk factors. Hospitals have an opportunity to utilize the patient experience as a teachable moment by educating on lifestyle and dietary changes. Additionally, the food choices offered to inpatients and outpatients can establish a paradigm for patients to adopt following discharge, with several US hospitals demonstrating novel initiatives.
Aggarwal M, Grady A, Desai D, et al. Am J Med, 2020. PMID 31494109
2020 / Narrative review
This review evaluated the benefits and risks of replacing sodium chloride with potassium-enriched salt substitutes. Empirical evidence shows that this replacement lowers systolic blood pressure by an average net delta of -5.58 mm Hg (95% CI: -7.08 to -4.09) and diastolic blood pressure by -2.88 mm Hg (95% CI: -3.93 to -1.83). Potential risks include hyperkalemia, arrhythmias, and sudden cardiac death, especially in individuals with impaired potassium excretion such as chronic kidney disease. However, the authors note there is currently insufficient evidence regarding the effects of these substitutes on the occurrence of hyperkalemia.
Greer RC, Marklund M, Anderson CAM, et al. Hypertension, 2020. PMID 31838902
2020 / Commentary / narrative review
This commentary criticizes five papers in the Annals of Internal Medicine that advised no need to reduce red or processed meat consumption based on low-certainty evidence from randomized trials and cohort studies. The author argues that red meat is a probable human carcinogen, processed meat is a definite carcinogen, and saturated fat raises heart disease risk. Additionally, the piece notes that vegetarians and vegans display superior lipid profiles, decreased chronic disease risk, and longer lifespans compared to meat eaters.
Potter JD, Jackson R Nutr Cancer, 2020. PMID 31842617
2020 / Narrative review
This review examined studies addressing mortality, health-span, and longevity-enhancing mechanisms in vegans and vegetarians. Epidemiologic studies consistently show lower disease rates, such as lower cancer and cardiovascular disease incidence, but mortality rates are comparable to vegetarians and occasional meat eaters. Vegan diets improve insulin resistance and dyslipidemia, and features like protein restriction or amino acid restriction (leucine or methionine) show potential life-span-enhancing effects. The review notes that vegan diets do not meet the nutritional requirements of children, pregnant women, or elderly individuals without adequate supplementation.
Shows an association, not proof of cause and effect.
Norman K, Klaus S Curr Opin Clin Nutr Metab Care, 2020. PMID 31895244
2020 / Narrative review of observational studies and randomized trials
This narrative review evaluated evidence from 8 observational studies and 8 randomized trials on whole-apple intake and cardiovascular disease risk factors. In the observational studies, apple intake was linked to lower CVD mortality, ischemic heart disease mortality, stroke mortality, all-cause mortality, severe abdominal aortic calcification, and lower C-reactive protein. In randomized trials, consuming whole apples reduced total cholesterol, LDL cholesterol, systolic blood pressure, pulse pressure, inflammatory cytokines, and CRP, while increasing HDL cholesterol and improving endothelial function. The review concluded that consuming 100 to 150 g/day of whole apples associates with lower CVD risk and benefits various risk markers.
Sandoval-Ramírez BA, Catalán Ú, Calderón-Pérez L, et al. Crit Rev Food Sci Nutr, 2020. PMID 31928209
2020 / Annual statistical report
The American Heart Association, together with the National Institutes of Health, annually updates statistics on heart disease, stroke, and cardiovascular risk factors including diet, physical activity, smoking, and weight. The 2020 update spans 26 chapters covering major circulatory conditions, outcomes, economic costs, social determinants of health, and the global burden of cardiovascular disease. It provides metrics to assess and monitor healthy diets and behaviors related to the AHA 2020 Impact Goals.
Virani SS, Alonso A, Benjamin EJ, et al. Circulation, 2020. PMID 31992061
2020 / Narrative review
This review examines clinical and epidemiologic evidence regarding dietary patterns that influence health and disease prevention. Patterns such as the Mediterranean, DASH, and MIND diets emphasize plant-based foods—including fresh fruits, vegetables, whole grains, legumes, seeds, and nuts—and feature lower intake of animal-based foods, especially fatty and processed meats. Evidence indicates that these dietary patterns reduce risks of non-communicable diseases, including cardiovascular disease and cancer.
Cena H, Calder PC Nutrients, 2020. PMID 32012681
2020 / Narrative review
This review examines the physiological and nutritional roles of taurine, creatine, carnosine, anserine, and 4-hydroxyproline, noting they are highly abundant in beef and mostly absent or negligible in plant foods. The authors state that consuming 30 g of dry beef can meet the daily physiological needs of a healthy 70-kg adult for taurine and carnosine. These nutrients play roles in anti-oxidative and anti-inflammatory pathways and are reported to benefit metabolic, cardiovascular, immune, neurological, skin, and bone health.
NANO counterpoint →
Wu G Amino Acids, 2020. PMID 32072297
2020 / Narrative review
This narrative review summarizes findings on resveratrol from epidemiological surveys, experimental studies, and clinical trials. The authors report that resveratrol exhibits antioxidant, anti-inflammatory, immunomodulatory, glucose and lipid regulatory, neuroprotective, and cardiovascular protective effects. Based on these mechanisms, it is noted to protect against diverse chronic conditions including cardiovascular diseases, cancer, liver diseases, obesity, diabetes, Alzheimer's disease, and Parkinson's disease.
Meng X, Zhou J, Zhao CN, et al. Foods, 2020. PMID 32183376
2020 / Literature review
Researchers performed a literature search in the PubMed/Medline database to assess the role of yoga in managing cardiovascular diseases (CVDs) and their risk factors. Out of 603 screened articles, 85 applicable articles were reported. The review suggests that yoga may act as an adjuvant in the management of CVDs and associated risk factors. However, limitations noted across studies included small sample sizes, differing types and durations of yoga interventions, and a lack of detail regarding the mechanisms underlying improvements.
Mooventhan A, Nivethitha L Explore (NY), 2020. PMID 32222372
2020 / Narrative review
This review examines the potential of a whole food plant-based (WFPB) diet to ameliorate chronic kidney disease (CKD). Evidence suggests a WFPB diet may slow CKD progression, decrease cardiovascular disease incidence, lower rates of diabetes and obesity, and reduce inflammation and cholesterol, thereby delaying kidney failure and dialysis initiation. Plant-based protein is reported to be alkaline-producing, anti-inflammatory, and renoprotective, contrasting with animal protein which promotes acidity, inflammation, and hyperfiltration. The authors note that macronutrient and micronutrient content must be carefully adjusted to prevent malnutrition, and further research is required to confirm biological plausibility and feasibility in CKD patients.
Adair KE, Bowden RG Nutrients, 2020. PMID 32268544
2020 / Narrative review
This review evaluates the ethnopharmacological therapeutic potential, mechanisms, efficacy, and safety of Ginseng, Ginkgo biloba, Ganoderma lucidum, and Gynostemma pentaphyllum for cardiovascular diseases. It synthesizes findings from in vitro, in vivo, and clinical trial studies covering conditions such as hypertension, coronary heart disease, myocardial infarction, cardiomyopathies, peripheral vascular diseases, and dyslipidemias. The authors emphasize that while these herbs demonstrate therapeutic promise against CVD risk factors, their claimed safety requires proper testing due to potential toxicity, adverse effects, and herb-drug interactions.
Shaito A, Thuan DTB, Phu HT, et al. Front Pharmacol, 2020. PMID 32317975